Alkermes plc

ALKS Healthcare Drug Manufacturers Specialty & Generic

Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.

Revenue
+21.8%
EPS
−80.6%
Free cash flow
+6.78%

Quarter to September 2026, against a year earlier

45.66 1.12 +2.51%
Market cap
$7.5B
P/E
0.0×
Fwd P/E
−85.9×
Dividend yield
—
F-score
7/9
Altman Z
5.33
Beneish M
−3.29
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
19.03 12.90 13.31 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
7 7 8 4 5 5 5 7 5 5
P/S ratio
3.12 3.05 2.86 3.55 2.97 2.84 2.55 3.89 8.73 10.61
Altman Z-Score
5.33 6.16 4.04 2.33 2.32 1.69 2.12 3.84 7.65 8.76
P/FCF ratio
9.57 11.71 13.45 0.00 47.10 71.46 0.00 140.36 0.00 0.00
Altman Z″-Score (non-manufacturers)
6.24 5.46 3.57 0.46 1.04 0.65 0.51 1.71 1.57 2.05
Beneish M-Score
(3.29) (2.19) (2.10) (2.73) (2.32) (2.87) (3.31) (3.01) (2.77) (2.77)
P/Operating CF
27.10 24.98 44.36 3,765.91 112.32 43.79 70.89 70.41 219.60 1,046.64
P/B ratio
2.53 3.25 3.96 3.78 3.13 2.76 2.75 3.64 6.56 6.54
EV/Sales
2.42 2.76 2.57 3.26 2.76 2.49 2.33 3.66 8.56 10.32
EV/EBITDA
12.73 9.56 8.74 50.54 18.39 0.00 0.00 882.80 0.00 0.00
EV/FCF
7.43 10.57 12.09 (210.78) 43.85 62.74 (151.66) 131.80 (242.06) (71.76)
Current Ratio
3.55 3.04 2.86 2.27 2.25 2.54 2.46 2.89 2.78 3.73
Net Debt/EBITDA
(4.69) (1.67) (0.99) (4.39) (1.36) 11.78 2.71 (57.37) 3.08 1.87
Debt/Equity
0.00 0.00 0.24 0.28 0.27 0.26 0.26 0.24 0.23 0.23
ROE
14.72% 27.52% 31.67% (14.68%) (4.42%) (10.30%) (17.43%) (11.74%) (13.10%) (16.52%)
ROA
10.64% 17.51% 17.35% (7.94%) (2.42%) (5.90%) (10.83%) (7.69%) (8.96%) (11.64%)
ROIC
31.75% 36.86% 35.95% (0.52%) 7.01% (9.94%) (13.25%) (6.80%) (8.80%) (13.10%)
Return on Tangible Assets
15.03% 31.17% 29.84% (18.50%) (5.17%) (10.84%) (21.07%) (14.61%) (19.68%) (24.71%)
Average Days of Receivables
82.61 90.11 72.96 94.54 97.39 96.68 80.14 97.47 94.38 93.54
Earnings Yield
5.25% 7.75% 7.51% (3.99%) (1.38%) (3.77%) (6.64%) (3.24%) (2.00%) (2.62%)
Free Cash Flow Yield
10.45% 8.54% 7.43% (0.44%) 2.12% 1.40% (0.60%) 0.71% (0.41%) (1.36%)
Free Cash Flow per Share
2.92 2.46 2.13 (0.11) 0.45 0.26 (0.11) 0.20 (0.21) (0.71)
Book value per Share
11.05 8.86 7.24 6.37 6.91 6.72 6.91 7.55 7.84 7.98
Free Cash Flow
481.42 406.10 353.66 (17.21) 72.98 41.27 (17.96) 30.36 (31.95) (107.26)
EV/EBIT
14.09 10.21 10.32 0.00 33.19 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026